Invention Grant
- Patent Title: NK-1 antagonist compositions and methods for use in treating depression
-
Application No.: US16612819Application Date: 2018-06-28
-
Publication No.: US11266633B2Publication Date: 2022-03-08
- Inventor: Thomas N. Chase , Kathleen E. Clarence-Smith
- Applicant: CHASE THERAPEUTICS CORPORATION
- Applicant Address: US DC Washington
- Assignee: CHASE THERAPEUTICS CORPORATION
- Current Assignee: CHASE THERAPEUTICS CORPORATION
- Current Assignee Address: US DC Washington
- Agency: Sughrue Mion, PLLC
- International Application: PCT/US2018/039883 WO 20180628
- International Announcement: WO2019/006050 WO 20190103
- Main IPC: A61K31/428
- IPC: A61K31/428 ; A61K31/438 ; A61K31/5377
Abstract:
The present invention describes the combination of a NK1-antagonist with pramipexole or a pharmaceutically acceptable salt or solvate thereof, useful for treating depressive disorders, including major depressive disorder.
Public/Granted literature
- US20200147053A1 NK-1 ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN TREATING DEPRESSION Public/Granted day:2020-05-14
Information query
IPC分类:
